Aktuellt
SENASTE
Redeye provides its initial take on the Q3’21 report and has a relatively neutral view all in all. A small deviation in expected vs actual performed surgeries results in sales below our estimates. Still, we emphasize its long-term prospects and note important fundaments laid in the quarter. We will return with an update where minor changes to our estimates and Base Case are likely.
LÄS MER
